EC Gynaecology

Introduction: Hypertensive disorder in pregnancy is 3^rd cause of maternal mortality, one of the major causes of maternal morbidity and also responsible for perinatal death resulting from prematurity and IUGR [1].

Aims: To estimate the serial serum uric acid and serial serum LDH level in women having hypertensive disorder of pregnancy (case) after 20 weeks of pregnancy till term to estimate the serial serum level of uric acid and serial serum LDH in normotensive pregnant women (control) after 20 weeks of pregnancy till term.

Materials and Methods: It was a comparative study conducted in the dept of OBG at ESIPGIMSR, ESIC Medical college, Joka, Kolkata for period of 18 month 124 patients were included.

Results: Patients were belong to 21-39 years. Primigravida were 53%. Multigravida were 42%. 70 patients were delivered by caesarean section.

Conclusion: Serum LDH and S uric acid values can be used as prognostic factor.

 Keywords: Serum Lactate Dehydrogenase (LDH); Serum Uric Acid (U.A); Pre-Eclampsia; Gestational Hypertension; Caesarean Section

1. DP Meshram., et al. “Maternal and foetal outcomes in pregnancy induced Hypertension-A Hospital based study”. International Journal of Pharmaceutical Science Invention4 (2014): 23-26.
2. Robinson Uchenna Ugwuanyi., et al. “Association between serum uric acid levels and perinatal outcome in women with preeclampsia”. Obstetrics and Gynecology International (2021): 6611828.
3. Borna S., et al. “Predictive value of mid trimester amniotic fluid highly sensitive C -reactive protein, ferritin, and lactate dehydrogenase for foetal growth restriction”. Indian Journal of Pathology and Microbiology4 (2009): 498-500.
4. Tsoi SC., et al. “Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A (4) isozyme in the endothelial cells of preeclampsia”. Placenta4 (2001): 317-322.
5. Liggy Andrews and Nikunj Patel. “Correlation of serum lactate dehydrogenase and pregnancy induced hypertension with its adverse outcomes”. International Journal of Research in Medical Science5 (2016).
6. Lincy J and Mathew G. “Estimation of serum LDH and serum uric acid in hypertension versus Normotensive pregnant women and its correlation with maternal outcome in a Tertiary care hospital”. International Journal of Innovative Research and Advanced Studies 3 (2016).
7. Asgharnia M., et al. “Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: A cross-sectional study”. International Journal of Reproductive BioMedicine 9 (2017): 583-588.
8. Sonagra AD., et al. “Serum LDH, ALP and uric acid in hypertensive disorders of pregnancy”. International Journal of Pharmacy and Biological Sciences3 (2012): 201-209.
9. Feig DI. “The role of uric acid in the pathogenesis of hypertension in the young”. Journal of Clinical Hypertension6 (2012): 346-352.
10. Pramanik T., et al. “Serum uric acid level in normal pregnant and preeclamptic ladies: a comparative study”. Nepal Medical College journal: NMCJ1 (2014): 30-32.
11. Qublan H., et al. “Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia”. Medical Science Monitor 8 (2005): CR393-CR397.
12. Gandhi M., et al. “Comparative study of serum LDH and uric acid in hypertensive versus normotensive pregnant woman”. International Journal of Biomedical Research 1 (2015): 25-28.
13. Babbar K., et al. “A comparative study of efficacy of antihypertensive drugs and fetomaternal outcome in the treatment of pregnancy induced hypertension”. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6 (2015): 1846-1852.
14. Vandana Ambasastha., et al. “Study of association of lateral implantation of placenta with development of pre-eclampsia and its outcomes”. The New Indian Journal of OBGYN1 (2018): 33-37.